 




<DOCTITLE>Cooperative Studies Evaluation Sub-Committee of the Advisory Committee for Cooperative Studies, and Health Services
and Rehabilitation Research and Development; Notice of Meeting</DOCTITLE>


The Department of Veterans Affairs gives notice under Public Law 92463 (Federal Advisory Committee Act) as
amended, by section 5(c) of Public Law 94409 that a meeting of the Cooperative Studies Evaluation Sub-Committee
of the Advisory Committee for Cooperative Studies, and Health Services and Rehabilitation Research and Development
will be held at the Royal Sonesta Hotel, 5 Cambridge Parkway, Cambridge, Massachusetts, on October 45, 1994.
The session on October 4 is scheduled to begin at 7:30 a.m. and end at 5:30 p.m. and on October 5 from 7:30 a.m. to 1:00 p.m.
The meeting will be for the purpose of reviewing five new clinical trials, one on varicella vaccine; one on prevention
of osteoporotic fractures, one on treatment of atrial fibrillation; one on coronary artery revascularization;
one on treatment of dysphagia from stroke and the progress of one on-going study on extracapscular cataract extraction.
The Committee advises the Director, Medical Research Service, through the Chief of the Cooperative Studies Program
on the relevance and feasibility of the studies, the adequacy of the protocols, and the scientific validity and propriety
of technical details, including protection of human subjects.
The meeting will be open to the public up to the seating capacity of the room from 7:30 a.m. to 8:00 a.m. on both days to
discuss the general status of the program. To assure adequate accommodations, those who plan to attend should contact
Dr. Ping Huang, Coordinator, Cooperative Studies Evaluation Sub-Committee of the Advisory Committee for Cooperative
Studies, and health Services and Rehabilitation Research and Development, Department of Veterans Affairs, Washington,
DC, (2025357154), prior to September 20, 1994.

The meeting will be closed from 8 a.m. to 5:30 p.m. on October 4, 1994, and from 8 a.m. to 1:00 p.m. on October 5, 1994, for
consideration of specific proposals in accordance with provisions set forth in section 10(d) of Public Law 92463,
as amended by section 5(c) of Public Law 94409, and 5 U.S.C. 552b(c)(6). During this portion of the meeting,
discussions and recommendations will deal with qualifications of personnel conducting the studies, staff and consultant
critiques of research protocols, and similar documents, and the medical records of patients who are study subjects,
the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.







Dated: August 24, 1994.



By direction of the Secretary.


<SIGNER>
Heyward Bannister,


</SIGNER>
<SIGNJOB>
Committee Management Officer.


</SIGNJOB>
<FRFILING>
[FR Doc. 9421856 Filed 9294; 8:45 am]


</FRFILING>
<BILLING>
BILLING CODE 832001M
</BILLING>



